Trial Profile
A study of inCVAX for the prevention of breast cancer
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 18 Sep 2016
Price :
$35
*
At a glance
- Drugs N-dihydro-galacto-chitosan (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 18 Sep 2016 According to an Immunophotonics media release, first patient is dosed in this study
- 18 Sep 2016 New trial record
- 23 Aug 2016 According to an Immunophotonics media release, the company plans for an US Investigational New Drug submission in 2017